{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["EMT", "Pirfenidone", "TGF-\u03b2", "breast cancer", "metastasis"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36651490", "DateCompleted": {"Year": "2023", "Month": "02", "Day": "07"}, "DateRevised": {"Year": "2023", "Month": "04", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "01", "Day": "18"}], "Language": ["eng"], "ELocationID": ["10.1111/jcmm.17673"], "Journal": {"ISSN": "1582-4934", "JournalIssue": {"Volume": "27", "Issue": "3", "PubDate": {"Year": "2023", "Month": "Feb"}}, "Title": "Journal of cellular and molecular medicine", "ISOAbbreviation": "J Cell Mol Med"}, "ArticleTitle": "Pirfenidone suppressed triple-negative breast cancer metastasis by inhibiting the activity of the TGF-\u03b2/SMAD pathway.", "Pagination": {"StartPage": "456", "EndPage": "469", "MedlinePgn": "456-469"}, "Abstract": {"AbstractText": ["Among breast cancer patients, metastases are the leading cause of death. Despite decades of effort, little progress has been made to improve the treatment of breast cancer metastases, especially triple-negative breast cancer (TNBC). The extracellular matrix plays an important role in tumour growth and metastasis by causing its deposition, remodelling, and signalling. As we know, the process of fibrosis results in excessive amounts of extracellular matrix being deposited within the cells. So, it will be interesting to study if the use of anti-fibrotic drugs in combination with conventional chemotherapy drugs can produce synergistic antitumor effects. In this study, we assessed the efficacy of Pirfenidone (PFD), an FDA-approved medication for the treatment of idiopathic pulmonary fibrosis, on TNBC cells as well as its anti-tumour effects in xenograft tumour model. PFD inhibited in a dose-dependent manner breast cancer cell proliferation, migration, and invasion, while promoted their apoptosis in vitro. PFD also suppressed TGF-\u03b2-induced activation of Smad signalling pathway and expression level of EMT-inducing transcription factors (e.g. SNAI2, TWIST1, ZEB1) as well as the mesenchymal genes such as VIMENTIN and N-Cadherin. On the contrary, the expression level of epithelial marker gene E-Cadherin was up-regulated in the presence of PFD. In vivo, PFD alone exerted a milder but significant anti-tumour effect than the chemotherapy drug nanoparticle albumin-bound paclitaxel (nab-PTX) did in the breast cancer xenograft mouse model. Interestingly, PFD synergistically boosted the cancer-killing effect of nab-PTX. Furthermore, Our data suggest that PFD suppressed breast cancer metastasis by inhibiting the activity of the TGF\u03b2/SMAD pathway."], "CopyrightInformation": "\u00a9 2023 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd."}, "AuthorList": [{"Identifier": ["0000-0002-6045-3971"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medical Sciences/School of Biology & Engineering, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Engineering Center of cellular immunotherapy of Guizhou Province, Guiyang, China."}, {"Identifier": [], "Affiliation": "Department of oncology, Affiliated Hospital of Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Department of oncology, Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China."}], "LastName": "Luo", "ForeName": "Daiqin", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medical Sciences/School of Biology & Engineering, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Engineering Center of cellular immunotherapy of Guizhou Province, Guiyang, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of infectious immunity and antibody engineering of Guizhou Province, Guiyang, China."}], "LastName": "Zeng", "ForeName": "Xianlin", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Public Health, Guizhou Medical University, Guiyang, China."}], "LastName": "Zhang", "ForeName": "Shuling", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medical Sciences/School of Biology & Engineering, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Engineering Center of cellular immunotherapy of Guizhou Province, Guiyang, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of infectious immunity and antibody engineering of Guizhou Province, Guiyang, China."}], "LastName": "Li", "ForeName": "Daohong", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Interventional Radiology, Affiliated Hospital of Guizhou Medical University, Guiyang, China."}], "LastName": "Cheng", "ForeName": "Zhimei", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medical Sciences/School of Biology & Engineering, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Engineering Center of cellular immunotherapy of Guizhou Province, Guiyang, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of infectious immunity and antibody engineering of Guizhou Province, Guiyang, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Functions & Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}], "LastName": "Wang", "ForeName": "Yun", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medical Sciences/School of Biology & Engineering, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Department of oncology, Affiliated Hospital of Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Department of oncology, Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China."}], "LastName": "Long", "ForeName": "Jinhua", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medical Sciences/School of Biology & Engineering, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Engineering Center of cellular immunotherapy of Guizhou Province, Guiyang, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of infectious immunity and antibody engineering of Guizhou Province, Guiyang, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Functions & Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}], "LastName": "Hu", "ForeName": "Zuquan", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medical Sciences/School of Biology & Engineering, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Engineering Center of cellular immunotherapy of Guizhou Province, Guiyang, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of infectious immunity and antibody engineering of Guizhou Province, Guiyang, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Functions & Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}], "LastName": "Long", "ForeName": "Shiqi", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medical Sciences/School of Biology & Engineering, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Engineering Center of cellular immunotherapy of Guizhou Province, Guiyang, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of infectious immunity and antibody engineering of Guizhou Province, Guiyang, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Functions & Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}], "LastName": "Zhou", "ForeName": "Jing", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Interventional Radiology, Affiliated Hospital of Guizhou Medical University, Guiyang, China."}], "LastName": "Zhang", "ForeName": "Shuai", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medical Sciences/School of Biology & Engineering, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Engineering Center of cellular immunotherapy of Guizhou Province, Guiyang, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of infectious immunity and antibody engineering of Guizhou Province, Guiyang, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Functions & Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}], "LastName": "Zeng", "ForeName": "Zhu", "Initials": "Z"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Cell Mol Med", "NlmUniqueID": "101083777", "ISSNLinking": "1582-1838"}, "ChemicalList": [{"RegistryNumber": "D7NLD2JX7U", "NameOfSubstance": "pirfenidone"}, {"RegistryNumber": "0", "NameOfSubstance": "Transforming Growth Factor beta"}, {"RegistryNumber": "0", "NameOfSubstance": "Smad Proteins"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Cell Movement"}, {"QualifierName": [], "DescriptorName": "Epithelial-Mesenchymal Transition"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["metabolism"], "DescriptorName": "Transforming Growth Factor beta"}, {"QualifierName": ["drug therapy", "genetics", "metabolism"], "DescriptorName": "Triple Negative Breast Neoplasms"}, {"QualifierName": ["metabolism"], "DescriptorName": "Smad Proteins"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201033. doi:10.3322/caac.21708", "ArticleIdList": ["10.3322/caac.21708", "35020204"]}, {"Citation": "Foulkes WD, Smith IE, Reis\u2010Filho JS. Triple\u2010negative breast cancer. N Engl J Med. 2010;363(20):1938\u20101948. doi:10.1056/NEJMra1001389", "ArticleIdList": ["10.1056/NEJMra1001389", "21067385"]}, {"Citation": "Dillekas H, Rogers MS, Straume O. Are 90% of deaths from cancer caused by metastases? Cancer Med. 2019;8(12):5574\u20105576. doi:10.1002/cam4.2474", "ArticleIdList": ["10.1002/cam4.2474", "PMC6745820", "31397113"]}, {"Citation": "Colpaert C, Vermeulen P, Van Marck E, Dirix L. The presence of a fibrotic focus is an independent predictor of early metastasis in lymph node\u2010negative breast cancer patients. Am J Surg Pathol. 2001;25(12):1557\u20101558. doi:10.1097/00000478-200112000-00016", "ArticleIdList": ["10.1097/00000478-200112000-00016", "11717549"]}, {"Citation": "Conklin MW, Eickhoff JC, Riching KM, et al. Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am J Pathol. 2011;178(3):1221\u20101232. doi:10.1016/j.ajpath.2010.11.076", "ArticleIdList": ["10.1016/j.ajpath.2010.11.076", "PMC3070581", "21356373"]}, {"Citation": "Hasebe T, Sasaki S, Imoto S, Mukai K, Yokose T, Ochiai A. Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: a prospective observational study. Mod Pathol. 2002;15(5):502\u2010516. doi:10.1038/modpathol.3880555", "ArticleIdList": ["10.1038/modpathol.3880555", "12011255"]}, {"Citation": "Levental KR, Yu H, Kass L, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009;139(5):891\u2010906. doi:10.1016/j.cell.2009.10.027", "ArticleIdList": ["10.1016/j.cell.2009.10.027", "PMC2788004", "19931152"]}, {"Citation": "Wang M, Zhao J, Zhang L, et al. Role of tumor microenvironment in tumorigenesis. J Cancer. 2017;8(5):761\u2010773. doi:10.7150/jca.17648", "ArticleIdList": ["10.7150/jca.17648", "PMC5381164", "28382138"]}, {"Citation": "Shen M, Kang Y. Complex interplay between tumor microenvironment and cancer therapy. Front Med. 2018;12(4):426\u2010439. doi:10.1007/s11684-018-0663-7", "ArticleIdList": ["10.1007/s11684-018-0663-7", "30097962"]}, {"Citation": "Patwardhan S, Mahadik P, Shetty O, Sen S. ECM stiffness\u2010tuned exosomes drive breast cancer motility through thrombospondin\u20101. Biomaterials Dec. 2021;279:121185. doi:10.1016/j.biomaterials.2021.121185", "ArticleIdList": ["10.1016/j.biomaterials.2021.121185", "34808560"]}, {"Citation": "Winkler J, Abisoye\u2010Ogunniyan A, Metcalf KJ, Werb Z. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat Commun. 2020;11(1):5120. doi:10.1038/s41467-020-18794-x", "ArticleIdList": ["10.1038/s41467-020-18794-x", "PMC7547708", "33037194"]}, {"Citation": "Xiong G, Deng L, Zhu J, Rychahou PG, Xu R. Prolyl\u20104\u2010hydroxylase \u03b1 subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition. BMC Cancer. 2014;14:1. doi:10.1186/1471-2407-14-1", "ArticleIdList": ["10.1186/1471-2407-14-1", "PMC3880410", "24383403"]}, {"Citation": "Fattet L, Jung HY, Matsumoto MW, et al. Matrix rigidity controls epithelial\u2010mesenchymal plasticity and tumor metastasis via a Mechanoresponsive EPHA2/LYN complex. Dev Cell. 2020;54(3):302\u2010316.e7. doi:10.1016/j.devcel.2020.05.031", "ArticleIdList": ["10.1016/j.devcel.2020.05.031", "PMC7423770", "32574556"]}, {"Citation": "DuChez BJ, Doyle AD, Dimitriadis EK, Yamada KM. Durotaxis by human cancer cells. Biophys J. 2019;116(4):670\u2010683. doi:10.1016/j.bpj.2019.01.009", "ArticleIdList": ["10.1016/j.bpj.2019.01.009", "PMC6382956", "30709621"]}, {"Citation": "Wei SC, Fattet L, Tsai JH, et al. Matrix stiffness drives epithelial\u2010mesenchymal transition and tumour metastasis through a TWIST1\u2010G3BP2 mechanotransduction pathway. Nat Cell Biol. 2015;17(5):678\u2010688. doi:10.1038/ncb3157", "ArticleIdList": ["10.1038/ncb3157", "PMC4452027", "25893917"]}, {"Citation": "Provenzano PP, Inman DR, Eliceiri KW, Keely PJ. Matrix density\u2010induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK\u2010ERK linkage. Oncogene. 2009;28(49):4326\u20104343. doi:10.1038/onc.2009.299", "ArticleIdList": ["10.1038/onc.2009.299", "PMC2795025", "19826415"]}, {"Citation": "Paszek MJ, Zahir N, Johnson KR, et al. Tensional homeostasis and the malignant phenotype. Cancer Cell. 2005;8(3):241\u2010254. doi:10.1016/j.ccr.2005.08.010", "ArticleIdList": ["10.1016/j.ccr.2005.08.010", "16169468"]}, {"Citation": "Taniguchi H, Ebina M, Kondoh Y, et al. Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J. 2010;35(4):821\u2010829. doi:10.1183/09031936.00005209", "ArticleIdList": ["10.1183/09031936.00005209", "19996196"]}, {"Citation": "Jin J, Togo S, Kadoya K, et al. Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor\u2010beta1. Respir Res. 2019;20(1):119. doi:10.1186/s12931-019-1093-z", "ArticleIdList": ["10.1186/s12931-019-1093-z", "PMC6558902", "31185973"]}, {"Citation": "Conte E, Gili E, Fagone E, Fruciano M, Iemmolo M, Vancheri C. Effect of pirfenidone on proliferation, TGF\u2010beta\u2010induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts. Eur J Pharm Sci. 2014;58:13\u201019. doi:10.1016/j.ejps.2014.02.014", "ArticleIdList": ["10.1016/j.ejps.2014.02.014", "24613900"]}, {"Citation": "Xu J, Lamouille S, Derynck R. TGF\u2010beta\u2010induced epithelial to mesenchymal transition. Cell Res. 2009;19(2):156\u2010172. doi:10.1038/cr.2009.5", "ArticleIdList": ["10.1038/cr.2009.5", "PMC4720263", "19153598"]}, {"Citation": "Kalluri R, Weinberg RA. The basics of epithelial\u2010mesenchymal transition. J Clin Invest. 2009;119(6):1420\u20101428. doi:10.1172/JCI39104", "ArticleIdList": ["10.1172/JCI39104", "PMC2689101", "19487818"]}, {"Citation": "Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial\u2010mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15(3):178\u2010196. doi:10.1038/nrm3758", "ArticleIdList": ["10.1038/nrm3758", "PMC4240281", "24556840"]}, {"Citation": "Yang J, Weinberg RA. Epithelial\u2010mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell. 2008;14(6):818\u2010829. doi:10.1016/j.devcel.2008.05.009", "ArticleIdList": ["10.1016/j.devcel.2008.05.009", "18539112"]}, {"Citation": "Guarino M, Rubino B, Ballabio G. The role of epithelial\u2010mesenchymal transition in cancer pathology. Pathology. 2007;39(3):305\u2010318. doi:10.1080/00313020701329914", "ArticleIdList": ["10.1080/00313020701329914", "17558857"]}, {"Citation": "Lu W, Kang Y. Epithelial\u2010mesenchymal plasticity in cancer progression and metastasis. Dev Cell. 2019;49(3):361\u2010374. doi:10.1016/j.devcel.2019.04.010", "ArticleIdList": ["10.1016/j.devcel.2019.04.010", "PMC6506183", "31063755"]}, {"Citation": "Mittal V. Epithelial mesenchymal transition in tumor metastasis. Annu Rev Pathol. 2018;13:395\u2010412. doi:10.1146/annurev-pathol-020117-043854", "ArticleIdList": ["10.1146/annurev-pathol-020117-043854", "29414248"]}, {"Citation": "Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor\u2010infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509\u2010W514. doi:10.1093/nar/gkaa407", "ArticleIdList": ["10.1093/nar/gkaa407", "PMC7319575", "32442275"]}, {"Citation": "Lanczky A, Gyorffy B. Web\u2010based survival analysis tool tailored for medical research (KMplot): development and implementation. J Med Internet Res. 2021;23(7):e27633. doi:10.2196/27633", "ArticleIdList": ["10.2196/27633", "PMC8367126", "34309564"]}, {"Citation": "Jezequel P, Campone M, Gouraud W, et al. Bc\u2010GenExMiner: an easy\u2010to\u2010use online platform for gene prognostic analyses in breast cancer. Breast Cancer Res Treat. 2012;131(3):765\u2010775. doi:10.1007/s10549-011-1457-7", "ArticleIdList": ["10.1007/s10549-011-1457-7", "21452023"]}, {"Citation": "Sapi J, Kovacs L, Drexler DA, Kocsis P, Gajari D, Sapi Z. Tumor volume estimation and quasi\u2010continuous Administration for Most Effective Bevacizumab Therapy. PLoS One. 2015;10(11):e0142190. doi:10.1371/journal.pone.0142190", "ArticleIdList": ["10.1371/journal.pone.0142190", "PMC4635016", "26540189"]}, {"Citation": "Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011;331(6024):1559\u20101564. doi:10.1126/science.1203543", "ArticleIdList": ["10.1126/science.1203543", "21436443"]}, {"Citation": "Heerboth S, Housman G, Leary M, et al. EMT and tumor metastasis. Clin Transl Med. 2015;4:6. doi:10.1186/s40169-015-0048-3", "ArticleIdList": ["10.1186/s40169-015-0048-3", "PMC4385028", "25852822"]}, {"Citation": "Tsai JH, Yang J. Epithelial\u2010mesenchymal plasticity in carcinoma metastasis. Genes Dev. 2013;27(20):2192\u20102206. doi:10.1101/gad.225334.113", "ArticleIdList": ["10.1101/gad.225334.113", "PMC3814640", "24142872"]}, {"Citation": "Takai K, Le A, Weaver VM, Werb Z. Targeting the cancer\u2010associated fibroblasts as a treatment in triple\u2010negative breast cancer. Oncotarget. 2016;7(50):82889\u201082901. doi:10.18632/oncotarget.12658", "ArticleIdList": ["10.18632/oncotarget.12658", "PMC5341254", "27756881"]}, {"Citation": "Koo BH, Kim Y, Je Cho Y, Kim DS. Distinct roles of transforming growth factor\u2010beta signaling and transforming growth factor\u2010beta receptor inhibitor SB431542 in the regulation of p21 expression. Eur J Pharmacol. 2015;764:413\u2010423. doi:10.1016/j.ejphar.2015.07.032", "ArticleIdList": ["10.1016/j.ejphar.2015.07.032", "26187313"]}, {"Citation": "Lei X, Yang J, Nichols RW, Sun LZ. Abrogation of TGFbeta signaling induces apoptosis through the modulation of MAP kinase pathways in breast cancer cells. Exp Cell Res. 2007;313(8):1687\u20101695. doi:10.1016/j.yexcr.2007.02.016", "ArticleIdList": ["10.1016/j.yexcr.2007.02.016", "PMC1905831", "17382930"]}, {"Citation": "Melisi D, Ishiyama S, Sclabas GM, et al. LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis. Mol Cancer Ther. 2008;7(4):829\u2010840. doi:10.1158/1535-7163.MCT-07-0337", "ArticleIdList": ["10.1158/1535-7163.MCT-07-0337", "PMC3088432", "18413796"]}, {"Citation": "Moreno\u2010Aspitia A, Perez EA. Nanoparticle albumin\u2010bound paclitaxel (ABI\u2010007): a newer taxane alternative in breast cancer. Future Oncol. 2005;1(6):755\u2010762. doi:10.2217/14796694.1.6.755", "ArticleIdList": ["10.2217/14796694.1.6.755", "16556053"]}, {"Citation": "Dhanapal R, Saraswathi T, Govind RN. Cancer cachexia. J Oral Maxillofac Pathol. 2011;15(3):257\u2010260. doi:10.4103/0973-029X.86670", "ArticleIdList": ["10.4103/0973-029X.86670", "PMC3227249", "22144825"]}, {"Citation": "Argiles JM, Busquets S, Stemmler B, Lopez\u2010Soriano FJ. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer. 2014;14(11):754\u2010762. doi:10.1038/nrc3829", "ArticleIdList": ["10.1038/nrc3829", "25291291"]}, {"Citation": "Derynck R, Akhurst RJ, Balmain A. TGF\u2010beta signaling in tumor suppression and cancer progression. Nat Genet. 2001;29(2):117\u2010129. doi:10.1038/ng1001-117", "ArticleIdList": ["10.1038/ng1001-117", "11586292"]}, {"Citation": "Wakefield LM, Roberts AB. TGF\u2010beta signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev. 2002;12(1):22\u201029. doi:10.1016/s0959-437x", "ArticleIdList": ["10.1016/s0959-437x", "11790550"]}, {"Citation": "Iyer SN, Gurujeyalakshmi G, Giri SN. Effects of pirfenidone on transforming growth factor\u2010beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. J Pharmacol Exp Ther. 1999;291(1):367\u2010373.", "ArticleIdList": ["10490926"]}, {"Citation": "Polydorou C, Mpekris F, Papageorgis P, Voutouri C, Stylianopoulos T. Pirfenidone normalizes the tumor microenvironment to improve chemotherapy. Oncotarget. 2017;8(15):24506\u201024517. doi:10.18632/oncotarget.15534", "ArticleIdList": ["10.18632/oncotarget.15534", "PMC5421866", "28445938"]}, {"Citation": "Di Sario A, Bendia E, Svegliati Baroni G, et al. Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production. J Hepatol Nov. 2002;37(5):584\u2010591. doi:10.1016/s0168-8278", "ArticleIdList": ["10.1016/s0168-8278", "12399223"]}, {"Citation": "Derynck R, Turley SJ, Akhurst RJ. TGFbeta biology in cancer progression and immunotherapy. Nat Rev Clin Oncol. 2021;18(1):9\u201034. doi:10.1038/s41571-020-0403-1", "ArticleIdList": ["10.1038/s41571-020-0403-1", "PMC9721352", "32710082"]}, {"Citation": "Wang J, Sergina N, Ko TC, Gong J, Brattain MG. Autocrine and exogenous transforming growth factor beta control cell cycle inhibition through pathways with different sensitivity. J Biol Chem. 2004;279(38):40237\u201040244. doi:10.1074/jbc.M401665200", "ArticleIdList": ["10.1074/jbc.M401665200", "15271980"]}, {"Citation": "Deckers M, van Dinther M, Buijs J, et al. The tumor suppressor Smad4 is required for transforming growth factor beta\u2010induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. Cancer Res. 2006;66(4):2202\u20102209. doi:10.1158/0008-5472.CAN-05-3560", "ArticleIdList": ["10.1158/0008-5472.CAN-05-3560", "16489022"]}, {"Citation": "Valcourt U, Kowanetz M, Niimi H, Heldin CH, Moustakas A. TGF\u2010beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial\u2010mesenchymal cell transition. Mol Biol Cell. 2005;16(4):1987\u20102002. doi:10.1091/mbc.e04-08-0658", "ArticleIdList": ["10.1091/mbc.e04-08-0658", "PMC1073677", "15689496"]}, {"Citation": "Herranz N, Pasini D, Diaz VM, et al. Polycomb complex 2 is required for E\u2010cadherin repression by the Snail1 transcription factor. Mol Cell Biol. 2008;28(15):4772\u20104781. doi:10.1128/MCB.00323-08", "ArticleIdList": ["10.1128/MCB.00323-08", "PMC2493371", "18519590"]}, {"Citation": "Sidiropoulos K, Viteri G, Sevilla C, et al. Reactome enhanced pathway visualization. Bioinformatics. 2017;33(21):3461\u20103467. doi:10.1093/bioinformatics/btx441", "ArticleIdList": ["10.1093/bioinformatics/btx441", "PMC5860170", "29077811"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "12", "Day": "20"}, {"Year": "2022", "Month": "8", "Day": "31"}, {"Year": "2023", "Month": "1", "Day": "4"}, {"Year": "2023", "Month": "1", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "18", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "1", "Day": "18"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36651490", "PMC9889661", "10.1111/jcmm.17673"]}}], "PubmedBookArticle": []}